US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

Amyris Fails To Get Final OK On $190M DIP Loan

By Leslie A. Pappas · September 14, 2023, 9:14 PM EDT

Bankrupt biochemical company Amyris Inc. failed to get final court approval Thursday for its $190 million post-petition financing after cannabinoid maker and creditor Lavvan Inc. raised a series of issues that...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Bankruptcy Scorecard

Summary

Synthesized biologicals producer Amyris filed for Chapter 11 bankruptcy protection in August with more than $1.1 billion in debt and plans to sell parts of its business. It received court approval of its $190 million debtor-in-possession loan.

Case Number

1:23-bk-11131

Judge

Thomas M. Horan

Venue

U.S. Bankruptcy Court for the District of Delaware

Capital Structure

Total Liabilities:

$1.1 billion

View Full Scorecard

Related Sections

Case Information

Case Title

Amyris, Inc.

Case Number

1:23-bk-11131

Court

Delaware

Nature of Suit

Date Filed

August 09, 2023

Recent Articles By Leslie